Aurinia Pharmaceuticals Inc.

SEC 4 · Filed

0001500210-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jun 4, 2026

Grant, award or other acquisition by Bailey Jeffrey Allen

Security
Director Stock Option (right to buy)
Code
A
Shares
23,931
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-06-04",
  "direction": "A",
  "exercise_price": "15.67",
  "expiration": "2036-06-04",
  "footnotes": {
    "F1": "The options shall vest one year from date of grant."
  },
  "owners": [
    {
      "cik": "0001500210",
      "name": "Bailey Jeffrey Allen",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "23931",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Director Stock Option (right to buy)",
  "shares": "23931",
  "table": "II",
  "underlying_security": "Common Shares",
  "underlying_shares": "23931"
}